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This  paper  presents  some  of  the  general  properties  and  characteristics 
of helenine.  These  properties  will  be  considered,  using  therapeutic  activity 
against  Columbia SK  encephalomyelitis  virus irdections  in mice as  the  cri- 
terion for helenine  activity  (1).  It will be assumed that the  therapeutic ac- 
tivity  of  various  crude  or  partially  purified  preparations  results  from  the 
presence  in  them  of  helenine.  Loss  of  therapeutic  activity  of  the  various 
preparations  resulting from some of  the procedures  to be  described  will  be 
considered  to result from alteration or destruction of helenine. 
GENERAL PROPERTIES 
Keeping ~ualitles of Hdenine.--Therapeutic activity is gradually lost by preparations of 
helenine kept  at  room temperature.  Similar preparations stored  in the refrigerator at  or 
near 5°C.  maintain their  therapeutic activity considerably longer and some preparations 
have maintained their full original activity for periods of a month or longer. Sterile filtrates 
of active preparations have appeared  to be more stable than unfiltered non-sterile mate- 
rials, suggesting that bacterial decomposition may play a role in helenine inactivation. 
Stored frozen under solid  CO2 helenine preparations have remained active for relatively 
long periods of time as indicated by the findings recorded  in Table I. 
Crude SPS preparations (supernatant fluid of pelilcles fragmented in a  Waring blendor 
(1)) remained apparently fully active for periods of 136, 143, and 314 days. Acetone precipi- 
tates of crude SPS preparations, reconstituted in water, retained their therapeutic activity 
for periods of 119, 127, and 145 days. Materials stored for longer periods have not been 
tested for retention of activity but it seems likely that,  at  the temperature of solid  CO~, 
heleuine will remain stable indefinitely. 
FiZtrabi~'y of He2en~ne.--Becanse of the  viscous  nature of  SPS preparations and their 
reconstituted acetone precipitates, filtration of helenine is a  very slow and tedious process. 
However,  to  obtain sterile preparations for crucial therapeutic tests in experimental ani- 
mals,  filtration through  Seitz pads presented  the  most dependable means of sterilization 
without inactivation or loss of material. 
As initially prepared by homogenizing SPS acetone precipitates with water in a  Warlng 
blendor a  turbid and very viscous preparation results. Such preparations are not  suitable 
for filtration through Seitz pads. If, however,  such turbid preparations are frozen slowly by 
placing them for 12 to 24 hours in the freezing compartment of an ordinary electric refrig- 
erator  and then thawed  without agitation, a  flocculent precipitate of viscous material is 
observed  floating in completely clear fluid. If this fluid is carefully poured through a gauze 
pad the flocculent precipitate is retained by the gauze and the filtrate is a clear amber fluid 
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which, while still viscous, is now slowly filtrable under pressure through a  Seitz pad.  The 
flocculent precipitate, which on a  dry weight basis is very small, is  completely devoid  of 
therapeutic activity.  Strangely, rapid freezing in the CO, box will not produce a  precipi- 
tate and slow freezing appears to be the essential step. 
TABLE  I 
K~INng Qualitias of Hdenine StareJ Frozen under C02 
Culture No.  Preparation  Storage  Survival index* 
Pooled 196--200 
BC 25A 
BC 25A 
BC 25 and 26 
Pooled 173 and 174 
C¢  ¢C  E~  tc 
BC 24 
BC 25A 
BC 25A 
SPS AP 2 X$ 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
sPs§ 
SPS 
SPS 
SPS 
SPS 
Frozen 145 days 
Fresh 
Frozen 127 days 
"  119  " 
Fresh 
Frozen 314 days 
"  143  " 
Fresh 
Frozen 136 days 
1.50 
1.53 
1.65 
1.58 
1.80 
1.65 
1.67 
1.52 
1.77 
* Tested in groups of 12 mice infected with SK virus. 
SPS AP 2 X, acetone precipitate of SPS concentrated 2 times. 
§ SPS,  superuatant fluid of pellides fragmented in a  Waring blendor (1). 
TABLE II 
Filtrability of ltdenine through Sei~: Pads 
Preparation  Unfiltered  Filtered 
Acetone preclpitste  Survlvsl index*  Survival index* 
4XPDQ 
3XPDQ 
SPSBC 56-61 
SPSBC 56-59 
SPSBC 48-55 
1.75 
1.64 
1.53 
1.87 
1.57 
1.55 
1.60 
1.70 
1.75 
1.52 
* Tested in groups d  12 mice infected with SK virus. 
Filtration of the gauze filtrate through a  Seitz pad results in no loss of either solids or 
therapeutic activity. The comparative activities of  several Seitz-filtered preparations with 
their corresponding gauze filtrates are given in Table II. 
The  small discrepancies in  the  survival indexes between  comparable  Seitz-filtered and 
unfiltered preparations recorded in the table are within the normal range of variation for 
tests in which therapeutic activity is determined in groups of 12 mice and it is believed that 
the results indicate that sterilization by Seitz pad filtration results in no loss or inactivation 
of helenine. 
Fa//ur¢  of fie/chine to  D/a/yze,--Dialysls  of  either SPS  preparations or  their reconsti- 
tuted acetone precipitates against repeated changes of cold distilled water in the refrigerator 
resulted in no detectable loss of helenine activity as indicated by the results of a  typical 
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In comparing preparations for therapeutic activity before and after dialysis corrections 
were made for the change in volume of the dialyzed materials by correspondingly varying 
the fluid volume administered therapeutically to the mice. It is believed that the small dis- 
crepancies  in  the  survival  indexes  between  dialyzed  and  non-dialyzed  preparations  are 
within the range of variation of  the test as  conducted and that the results indicate that 
helenine is not dialyzable under the conditions employed. 
The  Effect  of Freeze-Drying on  ttdenine.--During  the course  of  the  study  of helenine 
we  frequently wished  to  dry  active material without losing its  therapeutic  activity.  Our 
usual method was to dry under vacuum from the frozen state and we early found that SPS 
preparations dried in this manner possessed full activity when subsequently reconstituted 
with water  and  tested  therapeutically against  SK  virus infections in mice.  However,  the 
similar drying of semipurified preparations of helenine, notably those reconstituted in water 
after acetone precipitation, resulted in some loss of therapeutic activity during the process. 
That this loss was associated with the drying and not the freezing part of the process was 
indicated by the fact that acetone-precipitated helenine can be frozen repeatedly without 
TABLE  III 
Failure of Hdenine to DiM~e 
Preparation 
SPSBC 90 
SPSBC  90 (AP2 X)~ 
SPSBC 91 
SPSBC 91 (AP2 X) 
Before  dialysis 
Survival  index* 
1.51 
1.75 
1.30 
1.47 
After  dialysis 
Survival  index* 
1.51 
1.60 
1.22 
1.66 
* Tested in groups of 12 mice infected with SK virus. 
AP2 X, acetone precipitate concentrated two times. 
loss and that the best way to retain activity for long periods of time is by storage frozen 
in the wet state. 
The fact that SPS preparations could be freeze-dried without loss suggested that some- 
thing in such preparations, carried over from the medinm~ was capable of protecting hele- 
nine during the drying  process.  Preliminary experiments indicated that broth of the type 
utilized by P. funiculosum  in producing helenine, when added to acetone-precipitated hele- 
nine prior to freeze-drying, protected it against the loss of activity. A further series of tests 
of the capacity  of individual constituents of the broth to protect against loss of activity 
during freeze-drying have been carried out. The results of some of these tests are recorded 
in Table IV. 
As  shown  in  Table  IV,  none  of  the  four  SPS  preparations  lost  activity  as  a  result 
of  freeze-drying from  their natural  state  (water)  whereas  all  of  the  acetone-precipitated 
preparations that were freeze-dried from water lost variable amounts of activity during the 
process.  The remaining preparations shown in Table IV,  all of  them  acetone precipitates 
of SPS preparations, were freeze-dried either from broth, a solution of the salts of the broth, 
a 4 per cent solution of dextrose, or a  1 per cent solution of yeast extract. These concentra- 
tions of dextrose and yeast extract were selected because they corresponded to the concen- 
trations of these constituents in the broth and the salts too, were, of course, a  solution of 
the concentrations ordinarily used in the broth. 
The results shown in Table IV indicate that acetone-precipitated helenine can be dried 
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TABLE  IV 
The Effect of Freeze-Drying under Varying Conditions on t~ Therap~u~  Activity of gdenin¢ 
Preparation 
BC 17 
BC 17 
BC 25A 
BC 25A 
BC 26 
BC 26 
BC 26B 
BC 26B 
4XPDQ(A) 
4XPDQ (B) 
BC 9O 
BC64 
BC 56-62 
BC 62 
BC 56-59 
BC60 
BC 61 
BC 62 
BC 48-55 
BC 48-55 
State 
SPS 
SPS AP 5 X $ 
SPS 
SPS AP 1 X 
SPS 
SPS AP 1 X 
SPS 
SPS AP 1 × 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2 X 
SPS AP 2  X 
SPS AP 1  X 
Seitz filtrate of 
above 
Therapeutic activity expressed as survival indexes* 
against SK polioma~rel~i~roirus of preparation 
Nutrient  Salts of  1 per cent 
medium  medium  4  d  :r cent  yeast  Arose  extract 
.61 
1.34  1.75 
1.44  1.77 
1.53  .43  1.56 
Activity of 
original fluid 
preparation 
Survival  Water 
index* 
1.43  1.60 
1.81  1.24 
1.52  1.47 
1.53  1.36 
1.48  1.59 
1.42  1.19 
1.52  1.56 
1.43  1.22 
1.75  1.03 
1.71  1.43 
1.74  1.39 
1.64  1.32 
1.64  1.19 
1.66  1.40 
1.92  1.57 
1.61  1.25 
1.86  1.22 
1.86  1.30 
1.57  1.24 
1.52  1.36 
1.82  1.52 
1.59 
1.65  1.56 
1.78  1.48 
* Tested in groups of 12 to 30 mice infected with SK virus. 
:~ SPS  AP  5 X,  acetone precipitate  of  SPS  concentrated  5  times. 
TABLE  V 
Inactivation of Helenine by Heat 
Preparation  Heated  Activity against SK virus  Survival index* 
SPSBC25A 
SPSBC25A 
SPSBC25 AP 1 X 
SPSBC25 AP 1 X 
SPSBC56-59 AP 2 X 
SPSBC56-59 AP 2 X 
No 
Boiled 3 rain. 
No 
Boiled 3 rain. 
No 
Autoclaved, 15 lbs. 15 min. 
1.52 
1.24 
1.53 
1.27 
1.81 
1.05 
* Tested in groups of 18 or 30 mice. 
salts there appeared to be some loss of activity but probably less than that suffered during 
drying from water. Both 4 per cent dextrose and 1 per cent yeast extract appeared to exert 
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during the drying process. For routine purposes we have selected 4 per cent dextrose as 
the vehicle of choice for preserving the therapeutic activity of acetone-precipitated  helenine 
during the freeze-drying  process. 
Inactlvalion of Helenine by Hea/.--Helenine in an Erlenmeyer flask lost much of its ac- 
tivity when held for 3 minutes ha a boiling water bath. It was completely inactivated by 
autoclaving for 15 minutes at  15 pounds' pressure. The results are recorded in Table V. 
Interference in the Development of Viral Immunity by Treatment with Helenine 
Mice infected with either SK virus or Semliki Forest virus and saved by 
treatment with helenine may or may not be immune subsequently to infec- 
tion with the virus to which they were previously exposed. If, as rarely hap- 
pens in the case of SK virus, a  relatively large percentage of the mice have 
been  saved,  the  survivors will  usually  succumb  to  a  later exposure  to  the 
virus. If, on the other hand,  only a  small proportion of the mice have been 
saved by treatment with helenine, these will usually be solidly resistant  to 
infection on later exposure to the virus. The outcome of the test for immu- 
nity of mice  saved from SK virus  infection cannot,  however, be  predicted 
with certainty. 
In  the  case of Semliki Forest virus  infection, the  presence or absence of 
immunity in mice saved by treatment appears also to be somewhat depend- 
ent  upon  the  size  of the  initial  infecting dose  of  virus.  If  the  mice  have 
been  saved  by helenine,  following  a  small  but  surely  fatal dose  of  virus, 
the  survivors  are  not  likely to be  immune to fatal infection upon later ex- 
posure  to  virus.  If,  on  the  other hand,  the dose  of virus  from which  the 
mice have been initially saved is  a  relatively large  one,  then  the  survivors 
are usually solidly immune upon subsequent exposure to virus. 
Although,  as just pointed out, it is not possible to predict with  certainty 
whether or not mice  saved from death  by treatment  with  helenine  will  or 
will not be subsequently immune to viral infection, the same uncertain situa- 
tion does not hold in the case of mice saved by treatment with specific im- 
mune  serum.  Mice  infected  subcutaneously  with  either  SK  or  Semiliki 
Forest  virus  can all  be  saved if potent  specific virus-neutralizing  serum  is 
administered  intraperitoneally  to  them  3  or  4  hours  after  infection.  Mice 
saved in  this way by treatment  with  antiserum prove ahnost uniformly to 
be  solidly immune  when later exposed to viral infection of the  same  type. 
The virus-neutralizing serum used in  the present experiments was  obtained 
from swine recovered from intracerebral infection with  SK virus or Semliki 
Forest virus. Both of these agents produce a febrile, usually non-fatal enceph- 
alitis in swine when given intracerebrally. 
If mice infected with  either SK or Semliki Forest virus are  treated with 
both  helenine  and  specific  virus-neutralizing  serum  the  therapeutic  result 
achieved is similar to that obtained by treatment with the serum alone; that 
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the  development of immunity is  quite  different as indicated by the  results 
of the experiment recorded in Table VI. 
As shown in Table VI, 120 mice in four groups of 30 each were infected with SK virus. 
5 of the group treated with helenine, all of those treated with serum, and 24 of the group 
treated with the combination of helenine and serum  survived a  dose of virus that killed 
TABLE  VI 
Interference by t~denine with the Dcvdopmenl in Mice of Immunity to SK and Semliki Fores~ 
Viruses 
Infection subcutaneously 
with 
SK virus 
Semliki Forest virus 
Initia~ treatment* 
Helenine 
Anti-SK serum 
Both of above 
Controls 
Helenine 
Anti-Semliki serum 
Both of above 
Controls 
~urvivox 
5/30! 
30130 
24/30 
1/30 
11/24 
24/24 
24/24 
1/12 
Result of test for humunity~ 
Virus  Survivors 
SK virus 
New controls 
Semliki Forest 
virus 
New controls 
Not tested 
30/30 
13/24 
2/30 
9/n 
20/24 
7/24 
0/6 
* The SK virus-infected mice were treated intraperitoneally with helenine  and 24 hours 
after infection. The anti-SK serum was administered in two doses of 0.25 cc. each 3 and 24 
hours after infection. The group of mice treated with both helenine and anti-SK serum re- 
ceived the former approximately  15  minutes before the latter. The Semliki Forest virus- 
infected mice were  treated intraperitoneaUy with a  single dose of helenine 4  hours after 
infection. The anti-Semliki serum was administered in a  single 0.25 cc.  dose 4 hours after 
infection. The group of mice treated with both helenine and anti-Semliki serum received the 
former  approximately  15  minutes  before the latter. 
Test for immunity to SK virus made 15 clays after initial infection. Test for immunity 
to  Semliki Forest virus 20 days after initial infection. Challenge dose of virus given sub- 
cutaneously. 
§  Mice surviving 
No.  of  mice  in  group 
29 of 30 control mice. The reason for the loss of 6 mice in the group treated with the com- 
bination of helenine and serum is not clear, but it seems likely that the administration of 
the two materials may have resulted in a fatally toxic reaction in a few animals that neither 
material alone elicited. 
In testing the surviving mice for immunity to SK virus 15 days after their initial infec- 
tion it was found that, while all 30 of those that had been treated with serum alone were 
immune,  11  of  the  24  treated  with  both  helenine  and  serum were  not  immune  and 
succumbed to reinfection with SK virus. 
Obviously helenine in some manner prevented the virus given in the initial 
infection from eliciting  as  effective an  immune  response  as  it  did  in  mice 
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The  findings  in  the  case  of  the  Semliki  Forest  virus  infections  in  mice 
paralleled  quite  closely  those  obtained  with  SK  virus.  Helenine  saved  11 
of the 24 mice to which it was given while the serum,  alone and in combina- 
tion with helenine, saved all the 24 mice in each group. 
In testing the surviving mice for immunity to Semiiki Forest virus 20 days after their 
initial infection it was found,  as in the case of the SK virus mice, that a quite solid immu- 
nity had been conferred  on the group that had been treated with serum alone. Of this group 
20 of the 24 animals were found to have become immune. Of the group of 11 that had been 
saved by treatment with helenine  alone, 9 proved immune to the challenge infection.  The 
group that had been  treated with both helenine  and antiserum showed evidence however, 
of only a poor immunity, and of the 24 mice saved by the combined  treatment 17 proved 
not to be immune. 
TABLE VII 
Partial Composition of an Acetone Precipitate of SPS 
Determination  Found 
Nitrogen--total (Kjeldahl) ....................................... 
Phosphorous  total ............................................... 
Phosphorous  as free phosphate .................................... 
Phosphorous  bound--by difference ............................... 
Polysaccharides  ................................................. 
Reducing sugars, calculated as glucose ............................. 
Pentose sugars, calculated as rlbose .............................. 
~0er ~:ent * 
1.28,  1.30 
0.26, 0.27 
0.20, 0.22 
0.06, 0.05 
49.0,  54.0 
6.1,  6.1 
6.9,  7.1 
* Calculated on basis of solids present in sample. 
It seems likely that  the interference by helenine with the elicitation of an 
immune  response,  occurring  as  it  does  with  two  unrelated  viral  infections, 
represents  a  truly  reproducible  and  probably  significant  phenomenon,  one 
suggesting a  possible explanation of the  means  by which  helenine  exerts its 
therapeutic effect. This will be discussed more fully further on. 
Some Properties of an Acetone Precipitate of SPS I 
The preparation whose  analysis is to be outlined was a  reconstituted ace- 
tone  precipitate of  SPS  56--61  that  had  been  filtered through  a  Seitz  pad. 
It  had  been  reconstituted  in  distilled water  to  one-half  the  volume  of  the 
original SPS  from  which  it had  been  derived and  hence  had  two  times the 
concentration  of helenine  of  the  original  SPS.  Tested  against  SK  virus  in- 
fection  in  mice  it  was  therapeutically quite  active,  giving  a  survival  index 
of 1.70. 
The solution  for chemical tests was clear and amber colored, had a pH of 6.1, and con- 
tained 10 rag.  of acetone-precipitated material per ml.  It gave a positive Molisch  test for 
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carbohydrate and a  positive nlnhydrin test.  No precipitate was formed on addition of tri- 
chloracetic acid to a  final concentration of  10 per cent in a  10 rag. per ml. solution of the 
sample, indicating the absence of significant amounts of protein and the absence of signifi- 
cant amounts of nucleic acids. In the ultraviolet, a  1 mg. per ml. solution in water showed 
an absorption maximum at 2600 A,/~ per cent of 5.9,  which may indicate the presence of 
small amounts of nucleotides or nucleosides. 
Various chemical  determinations are outlined in Table VII. 
It is realized  that  with  no knowledge as  to  the relative  amount  of pure 
helenine  represented in the acetone-precipitated material,  the results of the 
chemical  tests  are  difficult  to  interpret.  However,  the  high  percentage  of 
polysaccharides found suggests that  this  class  of substances should be kept 
prominently in mind in any surmise,  at this stage of the investigation,  as to 
the character and nature of helenine. 
RECAPITULATION  AND  DISCUSSION 
Although the experiments described scarcely  touch upon the chemical na- 
ture of helenine they do present some of its  general  properties  and character- 
istics. The substance is not notably unstable if refrigerated  under sterile 
conditions,  and can be kept without serious  loss  in activity  for relatively  long 
periods of time when stored frozen  at the temperature of solid  C02. Acetone 
precipitation of helenine from  the crude  SPS  preparations does not ap- 
parently alter its keeping qualities so long as it is reconstituted in water and 
stored frozen under solid CO~. 
Filtration  of helenine  through  Seitz  pads  is  interfered  with  by the  tur- 
bidity and viscosity of reconstituted acetone-precipitated preparations. How- 
ever, slow freezing and thawing of such preparations brings down an inactive 
flocculent  precipitate  which  can  be  removed  by  filtration  through  gauze 
leaving  a  clear  amber fluid which contains all of the helenine  activity. This 
clear fluid  can  then  be filtered through  Seitz pads without loss of helenine 
activity. 
Although  helenine  is apparently  readily filterable it  does not pass a  dia- 
lyzing membrane.  Either in the crude SPS or after precipitation by acetone 
it remains within the bag when dialyzed against cold distilled water. 
The  effect of  freeze-drying upon  helenine  activity  is  determined  largely 
by the vehicle from which the drying is effected.  Crude SPS can be freeze- 
dried  without apparent  loss  of activity while  acetone-precipitated  helenine, 
reconstituted  in distilled water,  is frequently almost  completely inactivated 
by freeze-drying.  On  the  other  hand,  acetone-precipitated  helenine,  recon- 
stituted  in  broth  medium,  does not lose  activity on being freeze-dried.  Of 
the various  constituents  of the medium  that  might  be responsible for  this 
protective effect,  glucose and yeast extract appear to be more effective indi- 
vidually than do the salts of the medium. RICHARD E. SHOPE  647 
Heating  exerts  a  deleterious  effect on  helenine.  Exposure  for  3  minutes 
to  the  temperature of a  boiling water bath markedly decreases its activity 
and autoclaving for 15  minutes at  15  pounds' pressure  destroys it entirely. 
Determinations  of  some  of  the  chemical  properties  of  active  but  crude 
preparations  containing helenine have been made but  these  are  of little or 
no value in arriving at a knowledge of the chemical make-up of helenine be- 
cause we have no means of determining the relative amount of pure material 
contained  in  the  preparations  studied.  The  percentage  of  polysaccharide 
found was high but  this may or may not indicate  the  importance  of this 
class of substance in the make-up of helenine. 
Although the complete mechanism by which helenine acts in achieving a 
therapeutic effect against the SK and Semliki Forest viruses cannot be  de- 
cided from the information at hand, some phases of that information suggest 
possible  explanations for at  least portions  of the  mechanism of its  action. 
The role of helenine either in inhibiting SK virus multiplication or delaying 
its neuroinvasiveness has been pointed out in an earlier paper (1).  Subsequent 
work, especially that given in the present paper, has made possible additional 
surmises concerning the mode of action of helenine and some of these will be 
briefly discussed. 
The  achievement  of  maximum  therapeutic  action  with  relatively  small 
doses and  the  "plateauing" of effect would suggest that helenine acts only 
indirectly through some antiviral function of the host itself. The fact that 
very large doses or repeated doses frequently do not improve the therapeutic 
result obtained with smaller, optimal doses of helenine can perhaps be best 
explained on the basis of a  "triggering" function for helenine---a heavy pull 
on the  trigger of a  gun does not fire it any more completely or powerfully 
than does a  small but adequate pull. 
Whether helenine acts  directly on  the  virus  or  exerts  its  effect through 
triggering an antiviral function of the host, a  noteworthy finding in animals 
saved by helenine therapy has been the irregularity of subsequent immunity. 
Ordinarily, in the cases of the two viruses with which our experiments have 
been  largely  conducted,  SK  and  Semliki  Forest  viruses,  the  few  animals 
that  survive untreated  infections are  solidly immune.  However,  mice  that 
have been saved from either virus by treatment with helenine are frequently 
found to be still fully susceptible. This is especially true ff the infecting dose 
of virus from which they have been saved was a  small one. When the test 
has been a more severe one and the infecting dose of virus larger, then more 
of the mice saved by helenine therapy will be found subsequently immune. 
The  suggestion from such  results  is  that helenine therapy against minimal 
doses of virus exerts its effect, directly or indirectly, on the virus,  destroy- 
ing not only its infectivity, but its antigenicity as well.  In the case of larger 
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If the affected portion of the virus is great enough, and the unaffected por- 
tion small enough, the animal survives but acquires immunity by virtue of 
exposure to the unaffected portion of virus. 
In contrast to the irregular immunity found in animals saved by helenine 
therapy, those saved by treatment with specific virus-neutralizing serum are 
quite  regularly  immune  on  subsequent  challenge.  This  difference  in  end- 
result indicates that the mechanism by which helenine exerts its therapeutic 
effect is not the same as that by which the antiviral serum acts. Though both 
prevent the virus from progressing to a  fatal termination, the mechanism by 
which the antiviral serum acts is such that the antigenicity of the virus is 
not  destroyed.  The  mechanism by  which  helenine  acts  upon  the  virus  in 
arresting its progress,  on the other hand, is one involving destruction of its 
antigenicity. This  explanation presupposes  eventual action of the  two  sub- 
stances on the virus itself. If the assumption is made that the effect of both 
is not on the virus itself but on some stage in the cycle of virus multiplication 
then it would appear that the helenine effect takes place at an earlier stage 
than does that  of  the  antiserum--a  stage before  the  developing virus  has 
acquired the capacity to elicit an immune response. 
Some support for this second assumption is given by the results obtained 
in experiments in which viral infections were treated with both helenine and 
specific  antiviral serum. In these the therapeutic results achieved resembled 
those got by treatment with the serum alone. However, though all the ani- 
mals were saved by the combined therapy, they developed only a  poor im- 
munity  in  contrast  to  the  almost  perfect  immunity achieved  by  animals 
treated  with  serum  alone.  This  finding suggested  that  the  helenine  effect 
superseded  the  antiserum effect, yielding the  end-result  frequently seen  in 
animals  cured  by helenine  alone,  namely,  cure  without subsequent  immu- 
nity. This explanation would be more  compatible with the view that hele- 
nine exerts its therapeutic effect, either directly or indirectly, by acting to 
interfere with some stage of virus multiplication, than that it acts upon the 
fully developed virus itself, and that this action precedes that at which the 
antiserum exerts its effect. 
The results got by combined therapy with helenine and antiserum do not, 
of course, categorically rule out the possibility that both agents act directly 
on the virus itself; the helenine effect being to destroy it in such a way as to 
render it non-antigenic and the antiserum acting without destruction of viral 
antigenicity. Under such an explanation the therapeutic end-result expected 
would be the perfect one ordinarily achieved by treatment with serum alone. 
However, a  portion of the cures would have been effected by helenine with 
destruction of viral antigenicity and the remainder, that percentage of ani- 
mals ordinarily not cured by helenine alone, would have been achieved by 
the antiserum without destruction of viral antigenicity. Those mice then in 
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prove to be still susceptible while the remaining mice in which helenine had 
been incompletely effective and whose virus had been ultimately acted upon 
by antiserum would prove immune on subsequent challenge with virus. 
Three  products  of  microbial  metabolism  have  in  recent  years  been  re- 
ported  to exert a  therapeutic effect against certain of the viruses not ordi- 
narily affected by the  commercial antibiotics.  One  of these  is  the  polysac- 
charide substance  of Horsfall and McCarty  (2),  derived from various bac- 
terial species and active against the pneumonia virus of mice; another is an 
impurity in  certain  commercial  grades  of  penicillin found by  Group~  and 
Rake (3)  to have an in vitro  antiviral effect against some of the pox viruses; 
and the third is the antiviral substance recently reported by Powell and his 
coworkers  (4)  to  be  active  against  MM  and  Semliki  Forest  virus.  While 
helenine has  not been  tested  for  activity against  the  pneumonia  virus  of 
mice, or any of the pox viruses, there is little to make one suspect an identity 
between it and  either of the  first two  substances mentioned. The polysac- 
charide  of  Horsfall  and  McCarty,  unlike helenine,  has  no  therapeutic  ac- 
tivity  when  administered  intraperitoneaUy,  and  is  effective  against  pneu- 
monia virus of mice only when given intranasally. The material of Group~ 
and Rake exerts its effect upon the pox viruses only when incubated in vitro 
with  them prior  to  inoculation into embryonated eggs.  So  far as  we  have 
been able to determine, in the case of helenine, it does not exert an in vitro 
effect upon the viruses against which it is active and certainly in vitro  incu- 
bation with virus is not an essential method for observing its effect. While 
neither  the  polysaccharide substance  nor  the  penicillin impurity,  so  far  as 
can be  told from the published reports, has been tested for activity against 
either SK or Semliki Forest virus, their mechanism of action against viruses 
upon which they do exert an effect is so different from the means by which 
helenine  appears  to  act  that  there  seems  little  likelihood that  either  sub- 
stance is related in any direct way to helenine. Furthermore, helenine is de- 
stroyed by heating whereas both the other materials are  relatively thermo- 
stable. 
That helenine is distinct from the  antiviral substance  of Powell  and his 
coworkers can be  stated with much less  certainty.  In  fact,  much  of what 
Powell's group have  written in their preliminary publication on their anti- 
viral  substance  suggests  strongly that  helenine may be  related  to  it  very 
closely indeed, and may even be  the  same  substance.  The  closeness  of the 
relationship between  these  two  antiviral substances,  both  of  them derived 
from  penicillia,  or  their  actual  identity,  may perhaps  become  evident  on 
publication of the complete findings of Powell's group. 
$13MMARY 
Helenine is moderately stable  in solution at refrigerator temperature and 
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frozen at  the  temperature  of solid  CO,.  It is filterable through  a  Seitz pad 
but not dialyzable.  Crude SPS preparations  of helenine  do not lose activity 
when dried from  the frozen state.  Some  conditions are described, however, 
which influence  the preservation or inactivation of acetone-precipitated hele- 
nine  when freeze-dried.  Helenine is partially  inactivated  by exposure for 3 
minutes  to  the  temperature  of a  boiling  water bath  and  is  completely in- 
activated by autoclaving at 15 pounds' pressure for 15 minutes. 
The data presented suggest that  helenine  acts,  either directly or by trig- 
gering some mechanism of the host itself,  to destroy virus by a process which 
renders  the latter non-antigenic.  This effect may be exerted by action upon 
the virus itself or by interference with some stage in the developmental cycle 
of the virus. 
While the chemical  nature of helenine  is not known, the presence of a large 
proportion of polysaccharide in crude active preparations  might  suggest the 
possible importance  of this  class  of substance in helenine  activity.  It is be- 
lieved that helenine  differs from the polysaccharide reported by Horsfall and 
McCarty  and  the penicillin  impurity  reported  by Group~  and  Rake  to  be 
active against  certain viruses.  It  may be related,  however,  to  the antiviral 
substance recently reported by Powell and his co-workers. 
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